Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma.
- Resource Type
- Article
- Authors
- Leypoldt, Lisa B.; Tichy, Diana; Besemer, Britta; Hänel, Mathias; Raab, Marc S.; Mann, Christoph; Munder, Markus; Reinhardt, Hans Christian; Nogai, Axel; Görner, Martin; Ko, Yon-Dschun; de Wit, Maike; Salwender, Hans; Scheid, Christof; Graeven, Ullrich; Peceny, Rudolf; Staib, Peter; Dieing, Annette; Einsele, Hermann; Jauch, Anna
- Source
- Journal of Clinical Oncology; 1/1/2024, Vol. 42 Issue 1, p26-37, 21p
- Subject
- Language
- ISSN
- 0732183X